1 / 38

CHAPTER 6 IN THE SYLLABUS: Principles of Pharmacology

CHAPTER 6 IN THE SYLLABUS: Principles of Pharmacology. Dr. Robert L. Patrick Department of Neuroscience Brown University Robert_Patrick@brown.edu Biomed 370: January 12, 2005. PURPOSE OF TODAY’S LECTURE. To provide a basic introduction to pharmacological principles

hewitt
Télécharger la présentation

CHAPTER 6 IN THE SYLLABUS: Principles of Pharmacology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CHAPTER 6 IN THE SYLLABUS:Principles of Pharmacology Dr. Robert L. Patrick Department of Neuroscience Brown University Robert_Patrick@brown.edu Biomed 370: January 12, 2005

  2. PURPOSE OF TODAY’S LECTURE • To provide a basic introduction to pharmacological principles • To use these principles to help appreciate the approaches taken in the use of drugs to alter the activity of brain neurotransmitters

  3. WHAT IS PHARMACOLOGY? • Pharmacology is the science that deals with the mechanism of action, uses, and adverse effects of drugs • The word ‘pharmacology’ comes from the Greek word for drug: pharmakon

  4. DRUGS • Most common description: A substance used as a medicine for the treatment of disease. • In a larger context: A substance taken because of its biologically active properties. This would include substances such as caffeine, nicotine, alcohol, cannabis, heroin and cocaine.

  5. Source of Drugs • Natural: Plants, fungi, microrganisms • Semi-synthetic (making a chemical derivative of a natural product) • Synthetic

  6. Source of atropine: Atropabelladonna (deadly nightshade) Source of Digitalis: Digitalis Purpurea (foxglove)

  7. DRUG NAMESUSING ANTIDEPRESSANTS AS EXAMPLES • GENERIC: FLUOXETINE • PROPRIETARY: PROZAC • GENERIC: AMITRIPTYLINE • PROPRIETARY: ELAVIL • Q: Which are easier to remember?

  8. How Can Drugs Alter Brain Neurotransmitter Activity? • By altering some aspect of the Life Cycleof the transmitter: • Synthesis • Storage • Release • Receptor Interaction • Transmitter Inactivation

  9. What Are The Common Drug Targets? • Most common targets are body proteins: • Receptors: Can alter transmitter signaling • Example: Using risperidone to block dopamine receptors in schizophrenic patients • Enzymes: Can alter transmitter synthesis • Example: Using L-DOPA, a substrate for DOPA decarboxylase,to increase dopamine synthesis in the brains of patients with Parkinson’s Disease

  10. Drug Targets (con’t) • Transporters: Can alter transmitter inactivation • Example: Using fluoxetine (Prozac) to inhibit serotonin reuptake in depressed patients • Ion Channels: Can alter neuronal excitability • Example: Using phenytoin to block sodium channels in epileptic patients

  11. 3 Types of Neurotransmitters • Biogenic Amines: Acetylcholine, Dopamine,Norepinephrine, Epinephrine, Serotonin (can have either excitatory or inhibitory actions) • Amino Acids: Glutamatic acid (excitatory) GABA and Glycine (inhibitory) • Peptides: Enkephalins, Endorphins, Substance P (can be either excitatory or inhibitory)

  12. Drug Action • The degree of drug action at a target site will, in general, depend upon the drug concentration at that site

  13. And What Determines Drug Concentration? • Route of administration • Absorption and distribution • Binding • Inactivation • Excretion

  14. Entry Into The Brain • The brain can pose a problem for drug entry, due to the blood-brain barrier • A drug can gain entry into the brain if: • A. It is lipophilic, and can diffuse across membranes, or • B. A specific transport system exists that can carry (transport) the drug across membranes

  15. Drug Effects • What does a curve look like when you plot drug effect on the y-axis and dosage administered on the x-axis? • In words: You generate a dose-responsecurve! • In pictures: The shape of the curve depends upon whether you plot dosage or log of the dosage on the x-axis

  16. Points on the Curve • The maximal effect is called the efficacy • The amount of drug that produces 50% of the maximal effect is called the potency • The potency is often expressed as the ED50 • This means that the lower the ED50 the greater the potency (important point to remember!)

  17. Agonists and Antagonists • Agonist: An agent producing a cellular effect (e.g., norepinephrine stimulating the heart or acetylcholine inhibiting the heart) • Partial Agonist: Does not produce as great an efficacy as a full agonist (e.g., buprenorphine at opiate receptors) • Antagonist: An agent which blocks the effect of the agonist (e.g., atropine preventing acetylcholine action at the heart)

  18. THERAPEUTIC INDEX • Therapeutic Index (TI) = TD50 / ED50 • True or False?: If Drug A has a higher TD50 compared to Drug B, then Drug A must also have a higher therapeutic index.

More Related